CRISPR Therapeutics
CRSP
#3529
Rank
HK$31.91 B
Marketcap
HK$328.99
Share price
4.43%
Change (1 day)
-23.50%
Change (1 year)

EPS for CRISPR Therapeutics (CRSP)

EPS in 2026 (TTM): -HK$37.09

According to CRISPR Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$37.19. In 2025 the company made an earnings per share (EPS) of -HK$51.16 a decrease over its 2024 EPS that were of -HK$34.29.

EPS history for CRISPR Therapeutics from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$37.09-27.5%
2025-HK$51.1649.2%
2024-HK$34.29
2022-HK$65.67-267.74%
2021HK$39.15
2019HK$8.71-132.36%
2018-HK$26.91

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-HK$10.59-71.52%๐Ÿ‡บ๐Ÿ‡ธ USA